Industry-sponsored symposia and workshops | Association of Anaesthetists
Return to top

Industry-sponsored symposia and workshops



Industry-sponsored symposia and workshops

Industry-sponsored symposia


Wednesday 8 January 2020 - 12:35-13:35
Pre-operative Anaemia Management – Sharing Experiences and Success in the UK 
Location: St James Room, fourth floor (lunch provided)
Supported by Pharmacosmos UK, including funding of speakers



Wednesday 8 January 2020 - 12:35-13:35

Sustainability and Environmental Impact
Location: Westminster, fourth floor (lunch provided)
Speakers: 

• Mr Nigel Armstrong  Director talking about Armstrong Medical use of AMSORB
• Dr Seb Brown Consultant Anaesthestist & Research Director

 

Thursday 9 January 2020 - 13:00-14:00
Optiflow THRIVE: The WAMM Update 

Location: Westminster, fourth floor (lunch provided)
Speaker:
Dr Anil Patel, London   



Friday 10 January 2020 - 13:30-14:30
Ropivacaine: The UK’s best kept secret 
Location: Westminster, fourth floor (lunch provided)
Speaker:

• Dr Eric Albrecht, Programme Director Regional Anaesthesia, Lausanne, Switzerland 
• Dr Nigel Bedforth Consultant Anaesthetist, Nottingham
• Dr Morne Wolmarans, Consultant Anaesthetist, Nottingham
 

Industry-sponsored workshop


 
Thursday 9 January 2020 - 10:30 - 11:00
SuperNO2VA - A clinically superior method of oxygenating and ventilating without airway
Location: Westminster, fourth floor 

Speaker: Dr Michael Pedro, VP, Medical Director at Vyaire Medical
Sedation and anaesthesia have long been associated with high rates of hypoxemia and hypoventilation, which can ultimately result in Respiratory Compromise. The most dangerous situation in all of airway management is “can’t intubate, can’t ventilate,” where the clinician attempts both mask ventilation and endotracheal intubation, and fails at both. Since the patient is not receiving oxygen or eliminating CO2, they are at risk of oxygen desaturation, hypercarbia, and respiratory arrest.

The SuperNO2VA™ device is a nasal anaesthesia mask designed to effectively pre-oxygenate, maintain upper airway patency, provide continuous nasal oxygenation during apnea, and support ventilation in patients who are undergoing general anaesthesia, procedural sedation, or recovering in the post anaesthesia recovery unit (PACU). It was designed to address all of the objectives required to minimize the impact of respiratory compromise.